Evaluation of Treatment for Leukoderma by Cellular Level Resolution Full-field Optical Coherence Tomography

Chang Gung Medical Foundation

Status: Completed

Conditions: Leukoderma

Treatments: Device: ApolloVue® S100 Image System (Apollo Medical Optics)

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT04935424

20STW2-4-010-V1A3

Details and patient eligibility

About

OCT is an optical technology that emerged as a non-invasive skin imaging for the skin. In this protocol, the investigators plan to study the optical imaging features of leukoderma. An estimated 65 subjects will be included in this trial.

This is an observational, non-randomised, non-controlled, prospective cohort study to observe the feasibility of in vivo OCT as a image tool in the diagnosis of leukoderma. Use of the device will not affect the clinical management of the subjects.

Scientific Aim:

To evaluate the feasibility ApolloVue S100 image system as a tool in the differential diagnosis of leukoderma..

Enrollment: 65 patients

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Age ≧ 20
2. Subject with at least one leukoderma lesion
3. Willing to participate in the trial with informed consent

Exclusion criteria

1. Age < 20
2. Pregnant woman or woman wishing to be pregnant during the study, or during breastfeeding period
3. The investigators consider inappropriate to participate in the trial.
4. Open wound lesion.

Trial design

65 participants in 1 patient group

Experimental：Leukoderma

Description:

Device: ApolloVue® S100 image system

Treatment:

Device: ApolloVue® S100 Image System (Apollo Medical Optics)